Yao mingbio's resumption of work on the renewal of coronavirus epidemic situation

Since the outbreak of novel coronavirus pneumonia, drug Ming organisms have been paying close attention to the latest developments The management team is actively implementing the business continuity plan to mitigate the impact From now on, Yaoming bio's three operation bases in Wuxi, Shanghai and Suzhou will resume work in an all-round and orderly manner According to statistics, the total number of YaoMing biological employees who travel to, stop in or contact with residents from Wuhan during the Spring Festival is about 6% As of the time of publication, there were no confirmed cases of infection among the employees of YaoMing biology Yaomingbio continuously pays close attention to the health status of each employee, and has formulated and implemented strict prevention and control measures to ensure that the employee can return to work safely At present, 85% of employees have successfully returned to work, which can ensure the normal operation of the company's business Yaomingbio has not established an operation base in Wuhan, nor has it had a major supplier from Wuhan, so the supply of relevant materials required by the company's R & D and production has not been affected In addition, the sample and material transportation, import and export and customs clearance work are normal The company is also trying to ensure that the quality of its products is not affected by the outbreak Based on a strong GMP quality system and a robust global supply chain, the company does not expect to see any negative impact of the epidemic on its GMP production and operation In addition, for overseas customers who plan to visit China in the near future, the company will recommend video or teleconference to discuss relevant businesses Novel coronavirus has mobilized more than 240 scientists to set up a large-scale special tackling technical team and has been working closely with domestic and foreign enterprises to develop and produce multiple new coronavirus neutralizing antibodies, and accurately block the epidemic The in vitro efficacy test data of these neutralizing antibodies are expected to be completed next month At present, the novel coronavirus epidemic is still continuing This is another wake-up call for all employees of YaoMing biology: we must always do the right thing to benefit the vast number of patients Overall, the novel coronavirus epidemic has not been seriously affected by the new coronavirus outbreak Adorable adorable